Edition:
United States

Profile: Mesoblast Ltd (MSB.AX)

MSB.AX on Australia Stock Exchange

1.42AUD
15 Dec 2017
Change (% chg)

$0.07 (+5.19%)
Prev Close
$1.35
Open
$1.36
Day's High
$1.42
Day's Low
$1.35
Volume
3,417,501
Avg. Vol
1,754,249
52-wk High
$3.41
52-wk Low
$1.21

Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.

Company Address

Mesoblast Ltd

L 38 55 Collins St
MELBOURNE   VIC   3000
P: +613.96396036
F: +613.96396030

Company Web Links